Last reviewed · How we verify
NCT04962087
Health enSuite Insomnia: an App-based Treatment for Adult Chronic Insomnia
NA trial testing Experimental: Health enSuite Insomnia in Insomnia in 415 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | IWK Health Centre |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 415 |
| Start date | 29 August 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 1 July 2026 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Experimental: Health enSuite Insomnia
Conditions studied
- Insomnia — all drugs for Insomnia →
Sponsor
IWK Health Centre — full company profile →
Who can join
18 and older, any sex, with Insomnia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project consists of a randomized controlled trial. The objective of this trial is to test the effectiveness of an app-based cognitive behavioral program for insomnia (Health enSuite: Insomnia) in reducing insomnia symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04962087
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Insomnia
Currently open trials in the same condition.
- NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
- NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
- NCT07071324 — CF Wellness Program · NA · recruiting
- NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
- NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting
Other IWK Health Centre trials
Trials by the same sponsor.
- NCT06797076 — App-Based Migraine Treatment: The Health enSuite Study · NA · not yet recruiting
- NCT07112430 — Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants · Phase 1, PHASE2 · not yet recruiting
- NCT07165782 — Brief Videos Delivered by Text Messages as a Public Health Intervention for PTSD in Youth · NA · recruiting
- NCT06968377 — The COVID Dome Trial · NA · not yet recruiting
- NCT07284329 — Examining the Efficacy of a Digital Media Intervention to Increase Recruitment Rates · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04962087 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IWK Health Centre
- Last refreshed: 29 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04962087.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing